| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ARVINAS, INC. | Director | Common Stock | 30,166 | $195,174 | $6.47 | 25 Jun 2025 | Direct |
| ARVINAS, INC. | Director | Stock Option (right to buy) | 23,105 | $145,120 | $16.00 | 25 Jun 2025 | Direct |
| Sana Biotechnology, Inc. | EVP, Head of Development & CMO | Stock Options (Right to Buy) | 250,000 | 03 Mar 2022 | Direct | ||
| Astria Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 26,550 | 11 Jun 2025 | Direct | ||
| Calithera Biosciences, Inc. | Director | Stock Option (Right to Buy) | 20,000 | 01 Jun 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ARVN | ARVINAS, INC. | 25 Jun 2025 | 2 | $0 | 4 | Director | 30 Jun 2025, 06:14 |
| ATXS | Astria Therapeutics, Inc. | 11 Jun 2025 | 1 | $0 | 4 | Director | 12 Jun 2025, 19:16 |
| ARVN | ARVINAS, INC. | 29 May 2024 | 2 | $0 | 4 | Director | 31 May 2024, 17:52 |
| ATXS | Astria Therapeutics, Inc. | 08 Apr 2024 | 1 | $0 | 4 | Director | 09 Apr 2024, 08:11 |
| ATXS | Astria Therapeutics, Inc. | 05 Apr 2024 | 0 | $0 | 3 | Director | 09 Apr 2024, 08:09 |
| ARVN | ARVINAS, INC. | 15 Jun 2023 | 2 | $0 | 4 | Director | 20 Jun 2023, 17:25 |
| ARVN | ARVINAS, INC. | 15 Jun 2023 | 0 | $0 | 3 | Director | 20 Jun 2023, 17:24 |
| CALA | Calithera Biosciences, Inc. | 01 Jun 2022 | 1 | $0 | 4 | Director | 03 Jun 2022, 16:05 |
| SANA | Sana Biotechnology, Inc. | 03 Mar 2022 | 1 | $0 | 4 | EVP, Head of Development & CMO | 08 Mar 2022, 08:07 |
| SANA | Sana Biotechnology, Inc. | 15 Sep 2021 | 2 | -$1,564,057 | 4 | EVP, Head of Development & CMO | 17 Sep 2021, 16:27 |
| CALA | Calithera Biosciences, Inc. | 11 Jun 2021 | 1 | $0 | 4 | Director | 14 Jun 2021, 16:05 |